TLRY Tilray Brands Inc

$TLRY Simon has a track record of broadcasting his playbook before he executes. ​Remember when he signaled going after a Canadian medical play? Done. Hints about landing a UK brewer before the BrewDog deal? Done. ​The one major call he’s repeatedly emphasized that hasn't materialized yet is a true pharmaceutical partnership. He constantly pushes research, genetics, and clinical credibility. That’s not filler that’s positioning. ​Once federal legalization or rescheduling drops, don't be shocked when a sudden, massive pharma joint venture with a titan like Johnson & Johnson or Moderna hits the wire. That’s the real inflection point where valuation models break to the upside. ​Patience. The blueprint is already laid out. 🚀

$TLRY it always used to trade 2.5 to more than 3 times the price of acb. Holding 40000 shares, wont sell below 35 dollars

$TLRY I am buyer. I looked at my buying history since 2022 Jan and regret not pullingb buy lever more down here. Living learning. See you all at $30🤘

$TLRY so what we thinking? This quarter will show World Cup revenue... Will Irwin finally pull a profitable quarter?

$TLRY carlsberg deal is too big, when it gets in full swing even a volume of one billion dollar a yearvin revenue wou be easily achieved. we are sitting on a gold mine

$TLRY whoever the power that is that wants this price low (Citadel) is definitely in bed w brass but I think we all know the endgame. There will be huge upside. Buy these dips!

$TLRY earnings will surprise to the upside 2x your money soon most will miss out im a buyer

$TLRY looks like the shorts are focusing on US cannabis today. Couldn’t break down Tilly despite rising short interest. Now CTB has increased over 15% over the last week. Writing is on the wall and shorts are about to get 🔥. Mark it.

$TLRY The decision regarding Julius could be made starting Thursday, as the initial 30-day period will have elapsed by then; he also usually issues his rulings on Thursdays. Things will get tense between September 24 and October 12.

$TLRY Simon all talk about long term value, it’s been years with dilution and bad investments, don’t forget to vote for the annual meeting

$TLRY Medical breakthroughs and collaborations with big pharmaceutical and biotechnology companies will be where the windfall profits come from in this sector?

$TLRY Simon says: "By now, you all should know that the proxy vote is approaching. Nothing would make me happier than watching my most loyal supporters voting me in for another term for Chairman of the Board". "I have maintained my commitment of destroying every Tilray retail shareholder for the past 5+ years. This fiscal year, I focused on achieving that by announcing a totally unnecessary 1-10 reverse split on Thanksgiving weekend and quickly following it up with another 27% of further dilution (post reverse split)." "I will continue to make excuses on why this company's multi-faceted strategies never organically grow. And I will dedicate all my time in swiftly burning all the capital this company raises with its continuous dilution." "I believe I've earned every penny of my fiscal 2026 compensation in doing so: $22,157,305." "So, vote for me in this year's proxy for Chairman of the Board!" "I want to see if I can give myself another $20+ million in compensation (in consecutive years)."

$TLRY Hey Boris Jordan, CEO of Curaleaf! If your hostile acquisition of Aurora doesn't pan out, just make an offer for Tilray. I'll tender you ALL my shares for $14 each!

$TLRY there's a double bottom but it's got a lot of work ahead. ie close above the 50 and 100dma.

$TLRY : Clarifying the Debt Reduction! I want to issue an updated correction regarding the mechanics of the summer share dilution. Tilray has been systematically reducing its 5.20% convertible-note liabilities through three staggered debt-for-equity exchanges: 🗓️ June 15–24: $12M for 2,638,341 shares (~2.64M). 🗓️ August 4: $6M for 1,377,334 shares (~1.38M). 🗓️ August 31–September 8: $12M for 2,841,650 shares (~2.84M). Total: $30M senior-note principal retired for 6,857,325 shares. Dilution is a key variable to watch. But these swaps show Tilray using equity to cut 5.20% notes while targeting $68M–$75M FY2027 adjusted EBITDA. That's the balance-sheet tradeoff I'm watching: less debt, more shares, and whether operating performance continues to grow.

$TLRY There's a Nasdaq rule: Tilray cannot have more than 3 green days without a 38.2% to 50% retracement back down otherwise the Market Makers will dump on the bid to bring it down to bring the universe back into order 🤣

$TLRY after seeing that there are roughly 147.8 million shares are outstanding. Safe to say the $180 million ATM is done. They should announce that it has been completed before earnings. The rescheduling recommendation should happen before earnings. And the midterms people will bring it up in talking points. All signs lead to the share price should go up with cannabis moves. But I think they will keep hyping up the beer news. Because our management is terrible. 35,000 shares here. I just want to see $21

$TLRY 🔥🔥🔥 By holding onto those 15 to 18 inactive asset pieces (MedMen Stores/Licenses) right now, Tilray owns a massive pipeline of U.S. cannabis real estate that costs them almost nothing to maintain today, but will command a massive premium the moment the federal government finalizes the Schedule III transition.

$TLRY Simon has a tendency of "broadcasting" bullshit numbers when it comes to future forecast revenue. You can only imagine what occurs when it comes to Simon's"sleight of hand" associated with these continuous shit acquisitions that achieves ZERO increase in this company's profitability and his "compensation" sustained at 8-figures on a yearly basis.

$TLRY Back in 2018 when the partnership with a subsidiary of NVS was announced in Canada TLRY went up a little over eight percent on the same day.. According to AI partnerships take on average six months to one year.